why choose us

First received: September 13, 2022

Clinical Trial: Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer Patients

Study Type: INTERVENTIONAL


Official Title: A Clinical Study of Low-dose Radiotherapy Combined With Conventional Radiotherapy in Patients With Malignant Tumors After Immunotherapy Failure

Brief Summary: Response was evaluated according to the Guidelines for Response Criteria for Use in Trials Testing Immunotherapeutics (iRECIST) : ORR-To evaluate the objective effective rate of LDRT combined with SFRT and immunotherapy in patients with malignant tumors after immunotherapy resistance without standard regimens.PFS-To evaluate the progression-free survival (PFS) of patients with advanced malignant tumors after LDRT combined with SFRT and immunotherapy without standard regimens after immunotherapy resistance.DCR-To…

Read more